Expression changes and clinical significance of serum neuron-specific enolase and squamous cell carcinoma antigen in lung cancer patients after radiotherapy-Reference-Cited by-同舟云学术

Expression changes and clinical significance of serum neuron-specific enolase and squamous cell carcinoma antigen in lung cancer patients after radiotherapy

Published:2023-01 Issue: Volume:78 Page:100135
ISSN:1807-5932
Container-title:Clinics
language:en
Short-container-title:Clinics

Author:

Sun Lulu,Shao Qing^ORCID

Publisher

Elsevier BV

Subject

General Medicine

Reference19 articles.

1. Personalising lung cancer screening: An overview of risk-stratification opportunities and challenges;Ten Haaf;Int J Cancer,2021

2. Progress and prospects of early detection in lung cancer;Blandin;Open Biol,2017

3. Randomized trials of radiotherapy alone versus combined chemotherapy and radiotherapy in stages IIIa and IIIb nonsmall cell lung cancer: a meta-analysis;Marino;Cancer,2015

4. The efficacy and safety of EGFR-TKI combined with chemotherapy in Non-Small Cell Lung Cancer (NSCLC) patients with EGFR co-mutation with other oncogenic alterations;Yu;J Clin Oncol,2020

5. Multifunctional neuron-specific enolase: its role in lung diseases;Xu;Biosci Rep,2019

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and validation of a survival prediction model for patients with advanced non-small cell lung cancer based on LASSO regression;Frontiers in Immunology;2024-08-02

2. Comprehensive proteomic profiling of lung adenocarcinoma: development and validation of an innovative prognostic model;Translational Cancer Research;2024-05

3. Analysis of influencing factors of serum SCCA elevation in 309 CAP patients with normal CEA,NSE and CYFRA21-1;Frontiers in Oncology;2024-01-29

4. An advanced IVB lung adenocarcinoma patient with KRAS mutations, benefited from camrelizumab combined with anti- angiogenic agents for therapy: a case report;2024-01-22